This $113,163 federal contract was awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Center for Advancing Translational Sciences to MedChemExpress LLC, a New Jersey-based provider of biochemicals, bioactive compounds, peptides, and other life science research materials. The contract is for the delivery of 75 chemical compounds to support ongoing COVID-19 research. The award was made via a purchase order under a non-competitive combined...
This $16,035 firm-fixed price purchase order was awarded by the National Center for Advancing Translational Sciences (NCATS), a component of the U.S. Department of Health and Human Services, to MedChemExpress LLC, a New Jersey-based foreign-owned minority-owned small business. The award is for the acquisition of 2 grams of Minnelide (CAS: 1254702-87-8) and 10 grams of GNE-618 (CAS: 1362151-42-5), which are chemical compounds used to support NCATS' biomedical research programs. MedChemExpress has...
This $15,735 firm fixed-price purchase order was awarded by the National Institute of Dental and Craniofacial Research (NIDCR), a component of the National Institutes of Health (NIH), to MedChemExpress LLC, a New Jersey-based provider of chemical compounds and research materials. The contract is for chemical synthesis services to produce one chemical probe compound for delivery to NIDCR. No set-aside designation was used. MedChemExpress has previously served as both a prime contractor and...
This federal contract was awarded by the National Institutes of Health (NIH), which is a component of the Department of Health and Human Services (HHS), to MedChemExpress LLC, a New Jersey-based provider of biochemicals, bioactive compounds, and other life science research materials. The contract is for the custom synthesis of 30 grams of a single chemical intermediate, with a period of performance from July 2, 2021, to September 1, 2021. The award is a firm-fixed-price purchase order with a...
This is a $376,706 firm fixed-price purchase order contract awarded by the National Center for Advancing Translational Sciences (NCATS), a component of the U.S. Department of Health and Human Services, to MedChemExpress LLC, a small disadvantaged business located in New Jersey. The contract supports the SMALL MOLECULES FOR NCATS PHARMACOLOGICALLY ACTIVE CHEMICAL TOOLBOX (NPACT) program, providing chemical compounds and other scientific inputs for the agency's biomedical research initiatives....
The National Center for Advancing Translational Sciences, a component of the U.S. Department of Health and Human Services' National Institutes of Health, awarded a $22,226.00 firm fixed price purchase order to MedChemExpress LLC, a New Jersey-based provider of life science research materials. The contract is to obtain 5-milligram samples of biologically active small molecules with well-defined mechanisms of action. This material will be used to create the MIPE 5.1 molecular library, a collection...
This federal contract award was made by the National Center for Advancing Translational Sciences (NCATS), a component of the U.S. Department of Health and Human Services, to MedChemExpress LLC, a small disadvantaged business based in New Jersey. The $84,954 firm-fixed-price purchase order is for the provision of small molecules to support NCATS' Pharmacologically Active Chemical Toolbox (NPACT) program, which focuses on developing and evaluating chemical compounds for biomedical research. The...
Medchemexpress LLC was awarded a firm fixed price purchase order valued at seventy-seven thousand one hundred ninety-three dollars and forty-one cents ($77,193.41) by the Department of Health and Human Services' National Institutes of Health's National Institute on Drug Abuse to deliver one chemical library of five hundred nine bioactive compounds. The award originated from a sources sought notice issued by the National Institutes of Health's National Center for Advancing Translational...
This is a firm fixed-price purchase order awarded by the Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences to A1 Biochem Labs LLC, a small business, for the purchase of 34 intermediate chemical compounds in 5g quantities with purity greater than 95%. The total potential value of the award is $112,350.00. This requirement was set aside for total small business participation and is part of the agency's Coronavirus COVID-19...
<p>The U.S. Federal Agency, Office of Logistics and Acquisition Operations, awarded a Firm Fixed Price Purchase Order contract to 3Xper Innoventure LTD, a foreign-owned for-profit manufacturing organization, to MANUFACTURE THE SMALL MOLECULES TO INCREASE THE TRANSLATIONAL POTENTIAL. The contract has a ceiling value of $24,200.00 and a performance period ending on December 8, 2025. The contract was awarded on December 9, 2024 and does not have a set-aside designation.</p>